Clorox (CLX) Misses Q2 EPS by 18c, Guidance Misses Consensus

Clorox (NYSE: CLX) reported Q2 EPS of $0.66, $0.18 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.66 billion.

GUIDANCE:

Clorox sees FY2022 EPS of $4.25-$4.50, versus the consensus of $5.41.

• Net sales decline of 1% to 4% (organic sales decline of 1% to 4%)

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c